Literature DB >> 3676370

Decreased plasma serotonin in melancholic patients: a study with clomipramine.

M J Sarrias1, F Artigas, E Martínez, E Gelpí, E Alvarez, C Udina, M Casas.   

Abstract

Eighteen unmedicated patients suffering from major depressive disorder with melancholia (DSM-III) were examined for abnormalities in peripheral serotonin (5-HT) and related metabolites. Serotonin in platelet-free plasma and in platelets from melancholics was significantly reduced to 30% and 60% of their respective control values. Plasma 5-hydroxyindoleacetic acid was also found to be reduced, but not significantly. Other plasma compounds related to 5-HT (indoleacetic acid, total tryptophan, and free tryptophan) were found to be unchanged in these patients. Of all variables, only platelet 5-HT was affected while patients were on clomipramine (CIM) treatment. After 2 weeks on CIM (100-150 mg/day, orally), platelet 5-HT was reduced to 8% of pretreatment values, but plasma 5-HT did not change and continued to be reduced upon clinical recovery. The existence of a distinct pool of plasma 5-HT that is clearly independent of the platelet pool is indicated by the differences observed in plasma and platelet 5-HT during CIM treatment, as well as by previous data from this laboratory. The very marked decrease in plasma 5-HT levels may be in accord with the central nervous system changes reported in depression and suggests the possibility of using plasma 5-HT as a peripheral indicator of abnormal serotonin function in melancholia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3676370     DOI: 10.1016/0006-3223(87)90100-4

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  8 in total

1.  The Association of Salivary Serotonin With Mood and Cardio-Autonomic Function: A Preliminary Report.

Authors:  Michał Seweryn Karbownik; Steven Daniel Hicks
Journal:  Front Psychiatry       Date:  2022-05-31       Impact factor: 5.435

2.  Ect and platelet 5ht uptake in major depression.

Authors:  P K Dalal; N Lal; J K Trivedi; P K Seth; A K Agarwal; A Khalid
Journal:  Indian J Psychiatry       Date:  1997-10       Impact factor: 1.759

3.  Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine.

Authors:  J Ortiz; F Artigas
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

4.  Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium.

Authors:  F Artigas; M J Sarrias; E Martínez; E Gelpí; E Alvarez; C Udina
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.

Authors:  Craig H Mallinckrodt; John G Watkin; Chaofeng Liu; Madelaine M Wohlreich; Joel Raskin
Journal:  BMC Psychiatry       Date:  2005-01-04       Impact factor: 3.630

6.  Revisiting the role of raphe and serotonin in neuropsychiatric disorders.

Authors:  Albert Adell
Journal:  J Gen Physiol       Date:  2015-04       Impact factor: 4.086

7.  Editorial: Role of the serotonergic system in pathology of major depressive disorders.

Authors:  Trevor Ronald Norman
Journal:  Front Psychiatry       Date:  2022-08-08       Impact factor: 5.435

8.  Analysis of Serotonin in Human Feces Using Solid Phase Extraction and Column-Switching LC-MS/MS.

Authors:  Yukiko Hirabayashi; Kiminori Nakamura; Tsuyoshi Sonehara; Daisuke Suzuki; Satoru Hanzawa; Yu Shimizu; Tomoyasu Aizawa; Koshi Nakamura; Akiko Tamakoshi; Tokiyoshi Ayabe
Journal:  Mass Spectrom (Tokyo)       Date:  2020-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.